» Articles » PMID: 10155300

Epidemiology, Therapy and Costs of Nosocomial Infection

Overview
Specialty Pharmacology
Date 1995 Jan 8
PMID 10155300
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In the current climate of cost containment and quality control, nosocomial infection is a worrisome adverse event in hospital care. Hospitalised patients require care for increasingly severe illnesses, and are therefore more susceptible to infection, especially by opportunistic micro-organisms. It is thus necessary to accurately assess and adjust for the severity of the underlying illness in studies of risk factors involved in nosocomial infections. The appearance of new diagnostic and therapeutic techniques provides novel opportunities for infection control and represents a constant challenge to hospital systems. The continuous selection of resistant flora, together with the identification of new pathogens, calls for a reconsideration of hospital policies regarding the dispensation of antibiotics. Epidemiological surveillance continues to be the most important aspect of attempts to monitor infection control programmes, and to identify changes in risk factors that may increase the infection rate. Among the major challenges now facing the infection control practitioner is the use of nosocomial infection rates as an indicator of quality of care. Awareness of infection statistics would serve as a stimulus to the prevention and control of infection, but would be useless if not accompanied by adequate systems to guarantee the comparability of data from different studies and centres. Suitably sensitive and specific surveillance systems should be developed, and the use of site-specific and procedure-specific infection rates adjusted for the patient's intrinsic risk should be encouraged.

Citing Articles

Correlation between Overconfidence and Learning Motivation in Postgraduate Infection Prevention and Control Training.

Trifunovic-Koenig M, Bushuven S, Gerber B, Otto B, Dettenkofer M, Salm F Int J Environ Res Public Health. 2022; 19(9).

PMID: 35565171 PMC: 9100152. DOI: 10.3390/ijerph19095763.


Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.

Young M, Plosker G Pharmacoeconomics. 2001; 19(11):1135-75.

PMID: 11735679 DOI: 10.2165/00019053-200119110-00006.


Nosocomial infections in critically ill infectious disease patients: results of a 7-year focal surveillance.

Barsic B, Beus I, Marton E, Himbele J, Klinar I Infection. 1999; 27(1):16-22.

PMID: 10027101 DOI: 10.1007/BF02565165.

References
1.
Madison R, Afifi A . Definition and comparability of nosocomial infection rates. Am J Infect Control. 1982; 10(2):49-52. DOI: 10.1016/0196-6553(82)90002-5. View

2.
Haley R, Culver D, Morgan W, White J, Emori T, Hooton T . Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985; 121(2):206-15. DOI: 10.1093/oxfordjournals.aje.a113991. View

3.
Dinubile M . Antibiotics: the antipyretics of choice?. Am J Med. 1990; 89(6):787-8. DOI: 10.1016/0002-9343(90)90222-y. View

4.
Holbrook K, Nottebart V, Hameed S, Platt R . Automated postdischarge surveillance for postpartum and neonatal nosocomial infections. Am J Med. 1991; 91(3B):125S-130S. DOI: 10.1016/0002-9343(91)90357-4. View

5.
Haley R . Nosocomial infections in surgical patients: developing valid measures of intrinsic patient risk. Am J Med. 1991; 91(3B):145S-151S. DOI: 10.1016/0002-9343(91)90360-a. View